共 1 条
Concomitant Inhibition of IRE1α/XBP1 Axis of UPR and PARP: A Promising Therapeutic Approach against c-Myc and Gammaherpesvirus-Driven B-Cell Lymphomas
被引:4
|作者:
Benedetti, Rossella
[1
]
Arena, Andrea
[1
]
Romeo, Maria Anele
[1
]
Gilardini Montani, Maria Saveria
[1
]
Gonnella, Roberta
[1
]
Santarelli, Roberta
[1
]
Trivedi, Pankaj
[1
]
Cirone, Mara
[1
]
机构:
[1] Sapienza Univ Rome, Dept Expt Med, Viale Regina Elena 324, I-00161 Rome, Italy
关键词:
Burkitt lymphoma;
UPR;
IRE1;
alpha/XBP1;
c-Myc;
DDR;
BRCA-1;
CANCER-CELLS;
EXPRESSION;
MECHANISMS;
RESISTANCE;
LATENCY;
D O I:
10.3390/ijms23169113
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
It is emerging that targeting the adaptive functions of Unfolded Protein Response (UPR) may represent a promising anti-cancer therapeutic approach. This is particularly relevant for B-cell lymphomas, characterized by a high level of constitutive stress due to high c-Myc expression. In this study, we found that IRE1 alpha/XBP1 axis inhibition exerted a stronger cytotoxic effect compared to the inhibition of the other two UPR sensors, namely PERK and ATF6, in Burkitt lymphoma (BL) cells, in correlation with c-Myc downregulation. Interestingly, such an effect was more evident in Epstein-Barr virus (EBV)-negative BL cells or those cells expressing type I latency compared to type III latency BL cells. The other interesting finding of this study was that the inhibition of IRE1 alpha/XBP1 downregulated BRCA-1 and RAD51 and potentiated the cytotoxicity of PARP inhibitor AZD2661 against BL cells and also against Primary Effusion Lymphoma (PEL), another aggressive B-cell lymphoma driven by c-Myc and associated with gammaherpesvirus infection. These results suggest that combining the inhibition of UPR sensors, particularly IRE1 alpha/XBP1 axis, and molecules involved in DDR, such as PARP, could offer a new therapeutic opportunity for treating aggressive B-cell lymphomas such as BL and PEL.
引用
收藏
页数:13
相关论文